Stock Code: 300573 Stock Abbreviation: Xingqi Pharmaceutical Announcement No.: 2026-021 Shenyang Xingqi Pharmaceutical Co., Ltd. Notice of Convening the 2025 Annual General Meeting of Shareholders The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
I. Basic Information on Convening the Meeting
- Session of the Shareholders' Meeting: 2025 Annual General Meeting of Shareholders
- Convener of the Shareholders' Meeting: Board of Directors
- The convening and holding of this meeting comply with the "Company Law of the People's Republic of China," the "Shenzhen Stock Exchange GEM Stock Listing Rules," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 2 - Standardized Operation of GEM Listed Companies," and other laws, administrative regulations, departmental rules, normative documents, and the provisions of the "Articles of Association."
- Meeting Time: (1) On-site Meeting Time: May 13, 2026, 14:30 (2) Online Voting Time: The specific time for online voting through the Shenzhen Stock Exchange system is May 13, 2026, from 9:15-9:25, 9:30-11:30, and 13:00-15:00. The specific time for voting through the Shenzhen Stock Exchange Internet Voting System is any time from 9:15 to 15:00 on May 13, 2026.
- Method of Convening the Meeting: Combination of on-site voting and online voting.
- Equity Registration Date: May 8, 2026
- Attendees: (1) Common shareholders holding the Company's shares on the equity registration date or their authorized representatives. All common shareholders registered with China Securities Depository and Clearing Corporation Limited Shenzhen Branch as of the close of business on May 8, 2026, are entitled to attend this shareholders' meeting and may entrust an authorized representative in writing to attend the meeting and vote. Such authorized representative need not be a shareholder of the Company. (2) Directors and senior management personnel of the Company. (3) Lawyers and other relevant personnel engaged by the Company.
- Meeting Location: 30th Floor, Block B, Enterprise Plaza, No. 125 Qingnian Street, Shenhe District, Shenyang City.
II. Matters to be Submitted for Consideration at the Meeting
- Proposal List for this Shareholders' Meeting
| Proposal Code | Proposal Name | Proposal Type | Remarks: Checkbox for Voting |
|---|---|---|---|
| 100 | General Proposal: All proposals other than cumulative voting proposals | Non-cumulative voting | √ |
| 1.00 | Proposal on the <2025 Annual Work Report of the Board of Directors> | Non-cumulative voting | √ |
| 2.00 | Proposal on the <2025 Annual Financial Report> | Non-cumulative voting | √ |
| 3.00 | Proposal on the <2025 Annual Report> and its summary | Non-cumulative voting | √ |
| 4.00 | Proposal on the <2025 Profit Distribution Plan> | Non-cumulative voting | √ |
| 5.00 | Proposal on Re-appointing the 2026 Audit Firm | Non-cumulative voting | √ |
| 6.00 | Proposal on the <2025 Director Remuneration, Independent Director Allowances, and Projected 2026 Remuneration and Allowances> | Non-cumulative voting | √ |
| 7.00 | Proposal on <Formulating the Director and Senior Management Remuneration Management System> | Non-cumulative voting |